Workflow
Inspire(INSP)
icon
Search documents
Inspire(INSP) - 2024 Q1 - Quarterly Results
2024-05-07 20:02
Exhibit 99.1 Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook Inspire Reports Year-over-Year Revenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024 MINNEAPOLIS, Minnesota - May 7, 2024 - Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported f ...
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook
Newsfilter· 2024-05-07 20:02
Inspire Reports Year-over-YearRevenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024 MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2024. Recent Business Highlights Generated revenue of $164.0  ...
Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference
GlobeNewsWire· 2024-04-30 12:00
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024. Inspire is scheduled to present at 7:20 p.m. Eastern Time. The presentation will be accessible via a live webcast ...
Why You Should Add Inspire Medical (INSP) to Your Portfolio
Zacks Investment Research· 2024-04-18 17:21
Inspire Medical Systems, Inc. (INSP) has been gaining from its focus on research and development (R&D). The optimism led by a solid fourth-quarter 2023 performance and its global presence are expected to contribute further. However, concerns regarding overdependence on the Inspire system and a competitive landscape prevail.Over the past year, this Zacks Rank #1 (Strong Buy) stock has lost 8.1% compared with the 21.8% decline of the industry. The S&P 500 has witnessed 21.7% growth in the said time frame.The ...
Inspire (INSP) Surges 9.9%: Is This an Indication of Further Gains?
Zacks Investment Research· 2024-04-18 07:16
Inspire Medical Systems (INSP) shares rallied 9.9% in the last trading session to close at $243.51. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 8.4% gain over the past four weeks.Shares of the company surged likely in anticipation of improved earnings for its first quarter results scheduled to release on May 07, 2024. Loss estimates for the first quarter have narrowed in the past 30 days.This maker of dev ...
New Strong Buy Stocks for April 9th
Zacks Investment Research· 2024-04-09 11:16
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Surmodics, Inc. (SRDX) : This medical device coating technology provider has seen the Zacks Consensus Estimate for its current year earnings increasing 10.9% over the last 60 days.United States Steel Corporation (X) : This steel manufacturing company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.2% over the last 60 days.Telenor ASA (TELNY) : This telecommunication company has seen the Zacks Consensus ...
Inspire(INSP) - 2023 Q4 - Annual Report
2024-02-09 21:02
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 Inspire Medical Systems, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdi ...
Inspire(INSP) - 2023 Q4 - Earnings Call Transcript
2024-02-06 23:24
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2023 Earnings Conference Call February 6, 2024 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Adam Maeder - Piper Sandler Michael Sarcone - Jefferies Danielle Antalffy - UBS Richard Newitter - Truist Securities David Rescott - Baird Anthony Petrone - Mizuho Group Brett Fishman - KeyBanc Mike Kratky - Leerink Par ...
Inspire(INSP) - 2023 Q4 - Earnings Call Presentation
2024-02-06 22:10
1 Inspire Medical Systems, Inc. February 2024 NYSE: INSP This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' ''project,'' ''contemplate,'' ''bel ...
Inspire(INSP) - 2023 Q3 - Earnings Call Transcript
2023-11-08 05:22
Inspire Medical Systems, Inc. (NYSE:INSP) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President and Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Danielle Antalffy - UBS Securities LLC Robert Marcus - JPMorgan Chase & Co. Lei Huang - Wells Fargo & Company Travis Steed - Bank of America Jonathan Block - Stifel Financial Corp. Richard Newitter - Truist Securities ...